Mkts

Repligen Corporation

NASDAQ: RGEN
$178.94+5.45 (+3.14%)
As of Nov 9, 4:00 PM ET

Key statistics

Day range
172.39181.01
52-week range
100.99198.87
Today
Open174.29
Previous close178.94
Volume1.26M
Valuation
Market cap11.26B
P/E ratio268.52×
EPS (TTM)-0.21
Income & risk
Dividend / yield—
Beta1.17
Avg volume1.19M
Discussion

RGEN News

Stories mentioning RGEN from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue
Cost of Goods Sold85,97194,69688,29091,22477,801128,70677,38377,314
Gross Profit(85,971)(94,696)(88,290)(91,224)(77,801)(128,706)(77,383)(77,314)
Operating Expenses
Research & Development14,45813,93014,17513,95812,11411,6779,71010,575
Sales General & Admin76,53674,91273,66371,22770,70660,47475,61065,481
Total Operating Expenses
Operating Income (Loss)15,94017,86816,82513,8966,578(36,501)(7,832)5,469
Interest Income
Interest Expense4,981
Other Expense(750.00)403.00(804.00)3,502(286.00)(4,527)3,104(215.00)
Pretax Income1,77219,11317,11218,2157,943(38,608)(1,149)9,027
Tax Provision(6,561)5,8262,2013,3492,113(4,739)(495.00)3,314
Net Income (Loss)8,33313,28714,91114,8665,830(33,869)(654.00)5,713
Earnings Per Share (Basic)0.15237.270.270.260.10(604.80)(0.01)0.10
Earnings Per Share (Diluted)0.15233.110.260.260.10(604.80)(0.01)0.10
Weighted Average Shares Outstanding (Basic)56,35456.0056.0056.0056,12356.0056.0056.00
Weighted Average Shares Outstanding (Diluted)56,66657.0057.0057.0056,55856.0056.0056.00

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About RGEN

Repligen Corporation (NASDAQ: RGEN) is a stock listed on the Nasdaq Stock Market under the ticker symbol RGEN. It last traded at $178.94 (Nov 9, 2026, 4:00 PM ET), up 3.1% on the day. That gives Repligen a market capitalisation of $11.3B and a price-to-earnings ratio of 268.5.

Over the past 52 weeks RGEN has traded between $100.99 and $198.87.

Net income for the quarter ended Mar 31, 2026 was $8.3M.

Last 4 quarters
Quarter endedRevenueNet income
Mar 31, 2026—$8.3M
Dec 31, 2025—$13.3M
Sep 30, 2025—$14.9M
Jun 30, 2025—$14.9M

From Repligen’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…